Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Children’s Author, Melissa Perry Moraja Asking Tom Brady to Exchange Autographs at NFL Football Game On November 18th
  • USA - English


News provided by

Melissa Productions

Nov 13, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Type 1 Diabetic Childs Letter to Tom Brady
Type 1 Diabetic Childs Letter to Tom Brady

Charlotte, NC (PRWEB) November 13, 2013 -- Melissa Perry Moraja, mother of four and author and illustrator of numerous children’s books, asks Tom Brady, Patriots Quarterback and father to three young children, to exchange autographs at NFL Football Game on November 18th to build awareness and support for type 1 diabetes a disease that her twin daughter was diagnosed with on November 4, 2011.

Type 1 diabetic children need the support of pro athletes to give them hope that they too can beat all odds.

Post this

“I’m hoping that Tom Brady will help me build awareness and support for type 1 diabetes by autographing copies of my children’s books or a sports item with proceeds going to support type 1 diabetic children,” shares Melissa. “Becoming a pro athlete isn’t an easy task for a child living with type 1 diabetes as my daughter has shared in her letter to Mr. Brady. Having successful athletes like Tom Brady support and build awareness for this disease will give children hope that they can overcome their blood sugar challenges and pursue a career as a professional athlete.”

Melissa’s daughter was diagnosed with type 1 diabetes on November 4, 2011. Children living with this disease have to prick their fingers 8 – 12 times a day and are 100% insulin dependent until there is a cure. Managing a type 1 diabetic’s blood sugar isn’t easy. Everything affects it—the weather, what they eat, worrying about taking an exam, excitement during a sports tournament, and even dreaming during sleep.

“I was raised to believe the Patriots were a family’s team,” said Melissa, a native of New Hampshire and a New England Patriots fan. “My children’s books were written with the family in mind, promoting self-awareness and confidence. Type 1 diabetic children need hope and the support of family. And I hope Tom Brady will help support not only type 1 diabetes, but the role of a family on November 18th. This disease requires a family working together as a team!"

Melissa Perry Moraja will also be reading her newest Wunderkind Family children's chapter book at Children’s Story Time at the Southern Christmas Show on November 17th in Charlotte, NC, one a day before the Patriots vs. Panthers NFL game. She also welcomes Tom Brady and family at her event and would be happy to exchange autographs then, if it is more convenient. Her daughter and another type 1 diabetic child will be attending the event, giving Tom Brady an opportunity to meet and speak to them directly.

About Patriots, Tom Brady: Tom Brady was drafted by the New England Patriots in the sixth round (199th overall) of the 2000 NFL Draft.

About JDRF: The Juvenile Diabetes Research Foundation is a global leader in the fight against type 1 diabetes (T1D). Their mission is to discover, develop and deliver advances that cure, treat and prevent Type 1 Diabetes. For more information on JDRF please go to http://www.jdrf.org.

Type 1 Diabetes is an autoimmune disease where the insulin-producing beta cells in the pancreas have been destroyed. With type 2 diabetes a person’s pancreas isn’t producing enough insulin or their body has become insulin resistant a result of being overweight and not exercising.

About Melissa Productions, Inc.:
Melissa Perry Moraja is an entrepreneurial mom, a multifaceted business woman and a creative producer, authoring and illustrating numerous children’s stories and self-help books. Founded in 2009, Melissa Production’s mission is to offer humorous, inspirational products and services that promote self-awareness, creative learning, and leadership with the family in mind.With popular story book characters like Splatter, she speaks to children’s hearts through humor and parents thoughts by providing educational stories. For more information, please visit http://www.melissaproductions.com.

Contact:
Melissa Perry Moraja
Founder and CEO, Melissa Productions, Inc.
704-246-7304
http://www.melissaproductions.com

Melissa Perry Moraja, Melissa Productions, http://www.melissaproductions.com, +1 (704) 246-7304, [email protected]

Modal title

Children's authors type 1 diabetic daughter writes letter to Tom Brady
Children's authors type 1 diabetic daughter writes letter to Tom Brady
Children's authors type 1 diabetic daughter writes letter to Tom Brady

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.